Companies / Santa Cruz Biotechnology / Cytokeratin 7/17 (C46)
Santa Cruz Biotechnology

Cytokeratin 7/17 (C46) | Santa Cruz Biotechnology

mouse monoclonal IgG1; Cytokeratin 7/17 (also designated KRT7 antibody, Keratin 7 antibody, KRT17 antibody, Keratin 17 antibody) comprise a diverse group of intermediate filament proteins (IFPs) that are expressed as pairs in both keratinized and non-keratinized epithelial tissue. Cytokeratins play a critical role in differentiation and tissue specialization and function to maintain the overall structural integrity of epithelial cells. Cytokeratins have been found to be useful markers of tissue differentiation which is directly applicable to the characterization of malignant tumors. Cytokeratins 10 and 13 are expressed highly in a subset of squamous cell carcinomas while cytokeratin 18 is expressed in a majority of adenocarcinomas and basal cell carcinomas. Cytokeratin 7 is expressed in pancreatic duct cells and islets of Langerhans and is a marker for pancreatic duct cell differentiation. Cytokeratin 17 is normally expressed in complex epithelia basal cells and can be used as a marker for basal cell differentiation.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.